Crossref
MiR-300 regulate the malignancy of breast cancer by targeting p53 [Retraction]
International Journal of Clinical and Experimental Medicine · 2025
DOI: 10.62347/aroy7326 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Medicine, 2025. Verfasst von Xiao-Heng Xu.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Xu, X. (2025). MiR-300 regulate the malignancy of breast cancer by targeting p53 [Retraction]. International Journal of Clinical and Experimental Medicine. https://doi.org/10.62347/aroy7326
Vancouver
Xu X. MiR-300 regulate the malignancy of breast cancer by targeting p53 [Retraction]. International Journal of Clinical and Experimental Medicine. 2025. doi:10.62347/aroy7326
BibTeX
@article{Xu2025,
author = {Xu, Xiao-Heng},
title = {MiR-300 regulate the malignancy of breast cancer by targeting p53 [Retraction]},
journal = {International Journal of Clinical and Experimental Medicine},
year = {2025},
doi = {10.62347/aroy7326}
}
EUVIMED